A JAMA Psychiatry study published in February 2025 showed semaglutide significantly reduced drinking episodes in patients with alcohol use disorder through GLP-1 receptors in the mesolimbic dopamine system that modulate reward processing
As for preclinical studies, clinical trials are investigating the effects exercise has on NAD + metabolism
Consumers need to remember that compounded drugs have not been approved by the FDA and that these types of medications can carry risks, even if they arent disclosed in ads
Shows clear whitening before-and-after differences
Anti-Doping Agency (USADA) Mechanistic claims (angiogenesis modulation, nitric oxide pathway, cytoprotection) are preclinical
And thats no small deal in a country like India, where nearly 10 crore people live with diabetes, and a significant share also struggle with obesity